Insulet PODD
NASDAQ PODD
$134.96 -2.96 (-2.14%)
As of: Sep 10, 2026 · 2:51 PM EDT

Insulet (PODD) Change in Receivables (2010 - 2026)

Insulet's (PODD) quarterly Change in Receivables came in at $46.3 million in Q2 2026, up 217.12% on a YoY basis from $14.6 million in Q2 2025, and up 51.31% quarter-over-quarter from $30.6 million in Q1 2026.

Analysis

Insulet (PODD) Change in Receivables (2010 - 2026) Analysis & Trends

Insulet (PODD) has reported Change in Receivables for 15 consecutive years, with $46.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Change in Receivables rose 217.12% year-over-year to $46.3 million; the trailing twelve-month figure through Jun 2026 stood at $288.3 million (up 873.99% YoY), and the FY2025 full-year result was $253.2 million, up 1398.22% from the prior year.
  • Change in Receivables rose to $46.3 million in Q2 2026 per PODD's latest filing, from $30.6 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $209.8 million in Q4 2025 and bottomed at -$15.4 million in Q4 2022.
  • Historically, Change in Receivables has averaged $25.5 million across 5 years, with a median of $16.9 million in 2023.
  • The sharpest annual moves came in 2022 and 2025: Change in Receivables sank 178.57% in 2022, then jumped 5927.78% in 2025.
  • Over 5 years, Change in Receivables stood at -$15.4 million in 2022, then surged by 407.14% to $47.3 million in 2023, then sank by 107.61% to -$3.6 million in 2024, then surged by 5927.78% to $209.8 million in 2025, then sank by 77.93% to $46.3 million in 2026.
  • According to Business Quant data, Change in Receivables over the past three periods registered $46.3 million, $30.6 million, and $209.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Abbott Laboratories 180.55 Bn 174.95 Bn 7.27 Bn 386.00 Mn
2 Intuitive Surgical 127.52 Bn 122.30 Bn 1.96 Bn 74.90 Mn
3 Medtronic 117.07 Bn 108.26 Bn 6.34 Bn -224.00 Mn
4 Stryker 103.72 Bn 100.25 Bn 4.50 Bn 177.00 Mn
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn 46.00 Mn
6 Edwards Lifesciences 49.71 Bn 45.45 Bn 1.35 Bn 10.20 Mn
7 Alcon 33.00 Bn 31.55 Bn 1.68 Bn -
8 Dexcom 32.13 Bn 30.18 Bn 830.00 Mn 172.10 Mn
9 Steris 20.71 Bn 20.23 Bn 684.20 Mn -90.00 Mn
10 Insulet 9.31 Bn 8.77 Bn 562.60 Mn 46.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46.30 Mn
Mar 31, 2026 30.60 Mn
Dec 31, 2025 209.80 Mn
Sep 30, 2025 1.60 Mn
Jun 30, 2025 14.60 Mn
Mar 31, 2025 27.20 Mn
Dec 31, 2024 -3.60 Mn
Sep 30, 2024 -8.60 Mn
Jun 30, 2024 32.60 Mn
Mar 31, 2024 -3.50 Mn
Dec 31, 2023 47.30 Mn
Sep 30, 2023 25.00 Mn
Jun 30, 2023 7.90 Mn
Mar 31, 2023 19.20 Mn
Dec 31, 2022 -15.40 Mn
Sep 30, 2022 3.60 Mn
Jun 30, 2022 4.80 Mn
Mar 31, 2022 19.90 Mn
Dec 31, 2021 19.60 Mn
Sep 30, 2021 1.30 Mn